Skip to main content
logo
Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
76.32
-0.12 (-0.16%)
At close: Nov 5, 2026, 4:00 PM EST
76.28
-0.04 (-0.05%)
After-hours: Nov 5, 2026, 6:30 PM EST

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14
United States Revenue
-464.00M
International Revenue
-1.36B
Revenue (Total)
3.73B1.82B

Revenue

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14
Life Sciences Revenue
671.00M641.00M
Personal Care Revenue
592.00M577.00M
Specialty Additives Revenue
504.00M511.00M
Intermediates Revenue
135.00M137.00M
Eliminations from Revenue
-39.00M-42.00M
Revenue (Other)
1.86B-
Revenue (Total)
3.73B1.82B

EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14
Life Sciences Operating Income
131.00M-262.00M
Personal Care Operating Income
101.00M90.00M
Specialty Additives Operating Income
-12.00M-338.00M
Intermediates Operating Income
11.00M8.00M
Unallocated and Other Operating Income
-126.00M-273.00M
Operating Income (Other)
105.00M-
Operating Income (Total)
210.00M-775.00M

EBITDA

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14
Life Sciences EBITDA
--187.00M
Personal Care EBITDA
-155.00M
Specialty Additives EBITDA
--254.00M
Intermediates EBITDA
-21.00M
Unallocated and Other EBITDA
--273.00M
Operating Income (Total)
210.00M-775.00M

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14
Change in Sales Due to Volume
-98.00M
Change in Sales Due to Product Pricing/Mix
-46.00M